Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Everly Health, founded in 2015 and headquartered in Austin, Texas, is a pioneering e-commerce platform that offers at-home lab testing kits. The company enables customers to purchase a variety of health tests online, collect samples at home, and receive results without visiting a medical facility. Everly Health's product range includes sexual health, thyroid, metabolism, and men's health tests, among others.
Since its inception, Everly Health has successfully raised $255.55 million in funding, demonstrating investor confidence in its innovative approach to healthcare accessibility. The company's digital-first model aligns well with the growing trend of telemedicine and personalized health management.
While there is currently no official information available regarding Everly Health's IPO prospects, the company's significant funding and unique position in the healthcare technology sector may generate interest among potential investors. However, it's important to note that any discussions about a possible Everly Health IPO remain speculative at this time.
Factors that could influence Everly Health's decision to go public might include market conditions, the company's financial performance, and its long-term growth strategy. As the healthcare technology sector continues to evolve, Everly Health's progress and any future announcements regarding its plans will likely be of interest to those following the industry.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Everly Health's IPO prospects remain uncertain, investors eager to gain exposure to innovative healthcare technology companies don't have to wait. At Linqto, we offer members access to interests in pre-IPO private companies, including potential leaders in the health tech sector. Our platform allows you to diversify your portfolio with lower minimum investments in emerging industry pioneers like Everly Health, potentially benefiting from their growth before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
